Citadel Advisors’s Quanome Technologies QNME Stock Holding History

Citadel Advisors’s Portfolio QNME Stock Details QNME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26,049	Closed	-$18.2K	–	15099
2026 Q1	$18.2K	Buy	26,049 +3,261	+14%	+$2.59K	﹤0.01%	12690
2025 Q4	$20.3K	Sell	22,788 -10,758	-32%	-$11.3K	﹤0.01%	12341
2025 Q3	$43.3K	Sell	33,546 -1,400	-4%	-$1.38K	﹤0.01%	12261
2025 Q2	$29.7K	Buy	34,946 +16,127	+86%	+$15.6K	﹤0.01%	11980
2025 Q1	$20.3K	Buy	+18,819	New	+$33.5K	﹤0.01%	13132

Other funds holding QNME

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Citadel Advisors's QNME Position: Q2 2026 in Review

Citadel Advisors sold out of Quanome Technologies (QNME) in Q2 2026, closing a stake of 26,049 shares — an estimated $18.2K sold.

Citadel Advisors first reported a position in QNME in Q1 2025 and held it in 5 quarters. The position peaked at $43.3K in Q3 2025. 7 funds tracked by Wall St. Rank hold QNME as of Q2 2026.

Citadel Advisors reported no remaining Quanome Technologies position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 26,049 Quanome Technologies shares in Q2 2026, an estimated $18.2K.
Citadel Advisors first reported a position in Quanome Technologies in Q1 2025 and held it in 5 quarters.
Citadel Advisors's Quanome Technologies position peaked at $43.3K in Q3 2025.
7 funds tracked by Wall St. Rank held Quanome Technologies as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.